Kidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials.
Stefan D AnkerPiotr PonikowskiChristoph WannerEgon PfarrSibylle J HauskeBarbara PeilAfshin SalsaliIvana RitterAudrey Koitka-WeberMartina BrueckmannJoAnn LindenfeldWilliam T Abrahamnull nullPublished in: Circulation (2021)